Last reviewed · How we verify
NCT07492004: CMDR
China Monogenic Diabetes Registry
trial testing No Interventions in Neonatal Diabetes in 5,000 participants. Currently enrolling.
31 July 2030
Quick facts
| Lead sponsor | Tianjin Medical University General Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 28 February 2021 |
| Primary completion | 31 July 2030 |
| Estimated completion | 31 July 2030 |
| Sites | 1 location across China |
Drugs / interventions tested
- No Interventions — full drug profile →
Conditions studied
- Neonatal Diabetes — all drugs for Neonatal Diabetes →
- Monogenic Diabetes — all drugs for Monogenic Diabetes →
- Maturity Onset Diabetes of the Young — all drugs for Maturity Onset Diabetes of the Young →
Sponsor
Tianjin Medical University General Hospital
Who can join
Eligibility, any sex, with Neonatal Diabetes or Monogenic Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07492004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Interventions
Trials testing the same drug.
- NCT07473284 — Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients · not yet recruiting
- NCT07413380 — Effects of Arm Measurements on Upper Limb Skills and Reaction Time · NA · not yet recruiting
- NCT07536711 — Ego-Tucking: Exploring the Psychological Mechanisms of the "Fo-xi" Phenomenon Among University Students · completed
- NCT07409376 — Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in t · NA · not yet recruiting
- NCT07356115 — Association of High PainDETECT Scores With Pain Region and Diagnosis in Patients Attending a Musculoskeletal and Sports · recruiting
Other recruiting trials for Neonatal Diabetes
Currently open trials in the same condition.
- NCT03988764 — Monogenic Diabetes Misdiagnosed as Type 1 · recruiting
Other Tianjin Medical University General Hospital trials
Trials by the same sponsor.
- NCT06228781 — Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis · NA · not yet recruiting
- NCT07498595 — TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC · EARLY_PHASE1 · not yet recruiting
- NCT07498439 — TILs Therapy for Multiple Primary Early-Stage NSCLC · EARLY_PHASE1 · not yet recruiting
- NCT07018375 — The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Th · Phase 4 · not yet recruiting
- NCT07420296 — Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07492004 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Medical University General Hospital
- Last refreshed: 25 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07492004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing